Correction: DBP International AB: investee company Bio Vitos has yesterday reached agreement with Hemcheck
The correction refers to the letter in the press release on February 8 at 07:48 CEST: The MAR label was put there by mistake and the agreement between Bio Vitos and Hemcheck was signed yesterday. Double Bond Pharmaceutical International AB (publ) ("DBP") notes the announcement released earlier yesterday by Hemcheck Sweden AB (“Hemcheck”) and is pleased to announce that its 20% owned investee company Bio Vitos has today entered into an agreement with Hemcheck, a company listed on the Nasdaq Stockholm (the “Agreement”). As part of the Agreement Hemcheck will create a new subsidiary (“